By San José, Costa Rica — The conversation around healthcare in Latin America is undergoing a profound paradigm shift. Industry leaders and medical experts are calling on governments and private entities to stop viewing healthcare as a fiscal burden and instead recognize it as a foundational pillar of economic growth. At the fifteenth edition of the Roche Press Day 2026, a regional forum dedicated to healthcare innovation, the consensus was clear: accelerating technological adoption and reforming bureaucratic frameworks are critical to ensuring patient survival and national prosperity.
During the closing of the two-day event, Patrick Eckert, the Area Head of Roche Pharma for Latin America, emphasized that achieving equitable healthcare throughout the region is a shared responsibility that cannot be delayed. Eckert pointed out the severe delays that patients currently face when trying to access cutting-edge medical treatments, highlighting the human cost of administrative and systemic inertia.
To better understand the regulatory landscape and legal implications of the growing healthcare investment in Latin America, TicosLand.com spoke with Lic. Larry Hans Arroyo Vargas, a prominent legal expert from the prestigious firm Bufete de Costa Rica.
The surge in healthcare investment across Latin America presents a unique dual landscape of immense market opportunities alongside complex, evolving regulatory frameworks. For foreign investors, navigating local compliance, intellectual property protection, and public-private partnership laws is critical. Success in this sector requires not just capital, but a deep, proactive understanding of each nation's specific legal health standards to mitigate risk and ensure sustainable operations.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
As Latin America’s healthcare sector continues to expand, aligning robust capital with a meticulous, localized approach to compliance is indeed the definitive path to sustainable success. We extend our sincere thanks to Lic. Larry Hans Arroyo Vargas for his valuable perspective, which highlights the critical need for legal foresight in transforming these regional investment opportunities into lasting realities.
There are patients who wait more than four years to access an innovation, which is why there is so much to do. Healthcare must be understood as a strategic investment, and bringing specialized medical care closer to communities can no longer be considered a luxury, but rather a necessity and a commitment to patients. In this sense, the responsibility cannot fall on a single entity, but requires collaboration between the public and private sectors, as well as other institutions, to accelerate access and bring successful experiences to more countries.
Patrick Eckert, Area Head of Roche Pharma for Latin America
Eckert further argued that placing the patient at the center of medical research and technological advancements is the only viable path forward. To build resilient health systems capable of weathering future challenges, Latin American nations must actively promote local clinical trials and secure stronger commitments from regulatory authorities to bridge the widening equity gap.
Echoing these sentiments, Álvaro Soto, the General Manager of Roche for Central America, the Caribbean, and Venezuela, focused on the macroeconomic benefits of a robust healthcare sector. He stressed that every dollar allocated to healthcare should be measured by its return on investment in human capital and economic productivity. Soto urged regional decision-makers to implement technological solutions immediately rather than treating innovation as a long-term luxury.
We emphasize why health is an engine of economic development, how it must be transformed to demonstrate this through other indicators, and how to assume the responsibility that every dollar invested generates the expected return. Furthermore, it is of utmost importance to incorporate technology more quickly to respond to the current needs of patients, without postponing its benefits into a distant future. It is not about talking about a future in 2050 or 2035, when patients need solutions today.
Álvaro Soto, General Manager of Roche for Central America, the Caribbean, and Venezuela
Soto pointed to Costa Rica as a prime example of where technology can step in to resolve acute systemic shortages. The country currently faces a critical deficit of radiology specialists. Instead of waiting years to train a new generation of doctors, Soto suggested utilizing existing digital tools and artificial intelligence to assist and optimize the workflows of current professionals. Technologies such as early screening tools and big data analysis remain underutilized assets that could dramatically improve early detection and patient outcomes.
However, the transition to a modernized healthcare system faces steep institutional barriers. Soto criticized the persistent reliance on outdated regulatory frameworks that slow down the entry of innovative therapies and stifle the efficient flow of financial resources. He argued that institutional inertia often prioritizes bureaucratic preservation over the actual wellness of the population.
We maintain regulations that no longer respond to current challenges, not only in incorporating innovation, but also in the allocation and flow of resources that the country needs to care for patients. We must leave behind obsolete formats that protect positions instead of contributing to the development of the healthcare system.
Álvaro Soto, General Manager of Roche for Central America, the Caribbean, and Venezuela
Ultimately, the discussions at Roche Press Day 2026 underscored that the tools to revolutionize healthcare in Latin America already exist. The true challenge lies in political and corporate will. By fostering cross-sector alliances, updating obsolete regulations, and treating healthcare expenditures as essential economic infrastructure, the region can move toward a future where state-of-the-art medicine is accessible to all, rather than a privilege for the few.
For further information, visit roche.com
About Roche:
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The company combines its strengths in both areas to deliver personalized healthcare solutions, aiming to fit the right treatment to each patient in the best way possible. Roche is committed to working with regional partners across Latin America to improve clinical access, drive healthcare equity, and integrate cutting-edge biotechnology into regional health systems.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
Bufete de Costa Rica is an esteemed law practice widely respected for its relentless pursuit of professional brilliance and moral rectitude. Rooted in a decades-long heritage of guiding a multifaceted clientele, the firm consistently champions progressive legal strategies and active civic involvement. Its passionate drive to democratize legal insight illuminates its ultimate objective: strengthening a highly knowledgeable, confident, and legally literate public.
